Altace Related Clinical Trials
Higher Dose of Ramipril Versus Addition of Telmisartan-Ramipril in Hypertension and Diabetes [Terminated]
A 54 Week, Randomized, Double-Blind, Parallel-Group, Multicenter Study Evaluating the Long-Term Gastrointestinal (GI) Safety and Tolerability of Aliskiren (300 mg) Compared to Ramipril (10 mg) in Patients With Essential Hypertension [Recruiting]
Mechanisms of Ramipril Reduction in the Onset of Type 2 Diabetes [Recruiting]
Comparison of Awakening Versus Bedtime Dosing of Ramipril in Subjects With Essential Hypertension [Recruiting]
Efficacy and Safety Study of TAK-491 Compared to Ramipril for Treating Essential Hypertension [Recruiting]
Telmisartan (Micardis) and Ramipril (Altace) - Factorial Design Study for the Treatment of Hypertension [Completed]
HYZAAR vs. Ramipril for Diabetes [Completed]
China Medical University Hospital (CMUH) Triapin Listing [Recruiting]
PROBE Investigation of the Safety & Efficacy of Telmisartan (Micardis®) vs Ramipril (Altace®) Using ABPM in HTN [Completed]
Treatment of Pediatric Hypertension With Altace Trial [Completed]
Use of Ramipril and Felodipine Combination Therapy in Hypertension: An Effectiveness Study With Local Patients in Argentina [Completed]
Efficacy and Safety of Aliskiren +/- Ramipril When Added to Amlodipine in Hypertensive Patients With Metabolic Syndrome [Recruiting]
Studying the Effects of Antihypertensives on Individuals at Risk for Alzheimer's [Recruiting]
Safety and Efficacy of Aliskiren 300 mg, 150 mg and 75 mg in Patients With Essential Hypertension Compared to Ramipril 5 mg [Recruiting]
The Study of Atherosclerosis With Ramipril and Rosiglitazone [Active, not recruiting]
The DREAM (Diabetes Reduction Assessment With Ramipril and Rosiglitazone Medication) Trial [Active, not recruiting]
Compare the Effect of Aliskiren Plus Valsartan Versus Angiotensin-Converting Enzyme Inhibitor (ACEi) Plus Angiotensin Receptor Blocker (ARB) [Ramipril Plus Telmisartan] on the Renin-Angiotensin-Aldosterone System (RAAS) in Hypertensive Patients [Not yet recruiting]
A Safety and Efficacy Trial of Aliskiren 150mg , 300 mg Compared to Ramipril 5mg, 10mg in the Elderly [Completed]
Effects of Aliskiren, Ramipril, and the Combination on Levels of Angiotensin II in Patients With Systolic Heart Failure [Recruiting]
Study of the Efficacy and Safety of Aliskiren HCTZ vs Ramipril in Obese Patients (BMI ≥ 30) With Stage 2 Hypertension [Recruiting]
Safety and Efficacy of Ramipril in the Treatment of Essential Hypertension [Active, not recruiting]
Left Atrial Remodelling in Hypertension: Effects of Ramipril or Irbesartan [Recruiting]
Ramipril and Hydrochlorothiazide Alone and in Combination for the Treatment of Essential Hypertension [Completed]
Gene Expression Profiling in Skeletal Muscle of Healthy Subjects Treated With Ramipril [Recruiting]
Ramipril Versus Carvedilol in Duchenne and Becker Patients [Recruiting]
Ramipril in Rheumatoid Arthritis [Completed]
Bioequivalency Study of Ramipril 10 mg Capsules Under Fasting Conditions [Completed]
Bioequivalency Study of Ramipril 10 mg Capsules Under Fed Conditions [Completed]
The Effects of Ramipril on Clinical Symptoms in Patients With Peripheral Arterial Disease [Completed]
Irbesartan Versus Placebo in Combination With Ramipril for Treatment of Albuminuria [Completed]
A Study of the Effectiveness and Safety of Ramipril in the Treatment of Hypertension in Children and Adolescents [Terminated]
PRISMA = Prospective Randomised Investigation of the Safety and Efficacy of Micardis® vs Ramipril Using ABPM [Completed]
A Prospective, Randomized, Double-Blind, Double-Dummy, Forced Titration, Parallel Group Comparison, Multicenter Trial to Compare the Effects of Either Telmisartan (40-80 mg p.o. Once Daily) or Ramipril (5-10 mg p.o. Once Daily) on Renal Endothelial Dysfunction in Hypertensive Patients With Type 2 di [Completed]
Telmisartan Versus Ramipril After Acute Coronary Syndrome [Recruiting]
Study Evaluating the Effect of Ramipril on Urinary Protein Excretion in Renal Transplant Patients Converted to Sirolimus [Recruiting]
Angiotensin Converting Enzyme (ACE) Inhibition and Peripheral Arterial Disease [Recruiting]
Ramipril - Hypertension [Completed]
The Effect of Renin Angiotensin System Blockage (RAS) Blockade On PTX3 Levels In Diabetic Patients With Proteinuria [Completed]
Safety and Effects of Ramipril Combined With Candesartan [Completed]
A Clinical Study to Compare an Aliskiren Based Hypertensive Regimen With a Ramipril Based One Followed by a Randomized Withdrawal. [Completed]
To Investigate the Effect of Rosiglitazone and Ramipril on Pre-Clinical Vasculopathy in Diabetes and IGT Patients [Completed]
Effects of Angiotensin-Converting Enzyme Inhibitor (Ramipril) Therapy on Blood Vessel Inflammation [Completed]
FOCUS:Focus On Coronary Unstable Syndromes [Completed]
Study of Inflammation and Oxidative Stress in Persons Undergoing Dialysis [Recruiting]
The Indian POLYCAP Study (TIPS) [Recruiting]
Genes, Fibrinolysis and Endothelial Dysfunction- Dialysis Aim 3 [Not yet recruiting]
Italian Study on the Cardiovascular Effects of Systolic Blood Pressure Control - CARDIOSIS Study [Active, not recruiting]
Anti-Proteinuric Response to ACEI, ARB and Diuretics Combination. [Active, not recruiting]
A Clinical Study to Evaluate the Safety and Efficacy of Aliskiren Alone and in Combination With Ramipril in Hypertensive, Diabetic Patients. [Completed]
Efficacy and Safety of Aliskiren 300mg Compared to Irbesartan 300mg and Ramipril 10 mg in the Setting of a Missed Dose for Patients With Essential Hypertension. [Completed]
Efficacy and Safety of the Combination of Valsartan Plus Amlodipine in Hypertensive Patients Not Adequately Responding to the Combination Therapy With Ramipril Plus Felodipine [Completed]
Nephropathy In Type 2 Diabetes and Cardio-Renal Events [Active, not recruiting]
Serial BNP Measurements and Time to Disappearance of S3 in Goal-Directed Therapy of ADHF [Not yet recruiting]
Blood Pressure and Weight Trajectory on a Dual Antihypertensive Combination Plus Sibutramine Versus Placebo in Obese Hypertensives [Completed]
Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts [Recruiting]
ESCAPE Trial [Active, not recruiting]
Defining Strategies for Improving Endothelial and Fibrinolytic Dysfunction in Obesity [Recruiting]
The RAS, Fibrinolysis and Cardiopulmonary Bypass [Recruiting]
PREVENTKD (Prevent Risks by Early interVEntion at Nighttime in Type 1 Diabetes for Kidney Disease) [Recruiting]
Treatment of Immunoglobulin A (IgA) Nephropathy by Angiotensin-Converting Enzyme (ACE) Inhibitor [Active, not recruiting]
Angiotensin-converting-enzyme (ACE) Inhibitors in Hemodialysis [Recruiting]
Comparison of Eprosartan/HCT Versus Enalapril/HCT in Hypertensives With Type II Diabetes [Completed]
Goal-Directed Afterload Reduction in Acute Congestive Cardiac Decompensation Study [Recruiting]
Prognostic Value of the Circadian Pattern of Ambulatory Blood Pressure for Cardiovascular Risk Assessment [Recruiting]
African American Study of Kidney Disease and Hypertension ABPM Pilot Study [Recruiting]
Angiotensin-II Blockade in Mitral Regurgitation
Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus Erythematosis (SLE)
Comparison of Two Treatments to Decrease Inflammation and Atrial Fibrillation Following Cardiopulmonary Bypass Surgery
Evaluation of Heart Failure Treatment Guided by NTproBNP vs Clinical Symptoms and Signs Alone [Recruiting]
Prevention of Atrial Fibrillation by Inhibition Conversion Enzyme (ICE) After Radiofrequency Ablation of Atrial Flutter [Recruiting]
Renin-Angiotensin-Aldosterone System (RAAS), Inflammation, and Post-Operative Atrial Fibrillation [Recruiting]
Effects of Sodium Intake on(PK)/PD) Relationship of a Single Dose of a Renin Angiotensin System-Blocker [Recruiting]
Using the Drug Spironolactone to Test If It Reduces Protein Leakage From the Kidney [Completed]
|
